Cory M Hubler (Cory Hubler)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Escherichia Coli

Urinary Tract Infection

Biofilm Formation

Intensive Care Unit

Top Venues

Antibiotics (Basel, Switzerland)

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Helio Silva Sader, Rodrigo E Mendes, John H Kimbrough, Cory M Hubler, Mariana Castanheira
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients. Antibiotics (Basel, Switzerland) 13 (6) (2024)
Helio Silva Sader, Rodrigo E Mendes, John H Kimbrough, Cory M Hubler, Mariana Castanheira
Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients. Antibiotics (Basel, Switzerland) 13 (6) (2024)
Rodrigo Elisandro Mendes, Cory M Hubler, John H Kimbrough, Valerie Kantro, Ian A Critchley, Nicole Cotroneo, Mariana Castanheira
In Vitro Activity of Tebipenem against Various Resistant Subsets of Escherichia coli Causing Urinary Tract Infections in the United States (2018 to 2020). Antimicrobial agents and chemotherapy 66 (10) (2022)